Casey B Cempre
Overview
Explore the profile of Casey B Cempre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hing Z, Walker J, Whipp E, Brinton L, Cannon M, Zhang P, et al.
Nat Commun
. 2023 Jan;
14(1):97.
PMID: 36609611
Richter's Transformation (RT) is a poorly understood and fatal progression of chronic lymphocytic leukemia (CLL) manifesting histologically as diffuse large B-cell lymphoma. Protein arginine methyltransferase 5 (PRMT5) is implicated in...
2.
Zhang P, Brinton L, Gharghabi M, Sher S, Williams K, Cannon M, et al.
Sci Adv
. 2022 Sep;
8(37):eabp9005.
PMID: 36112677
Using a genome-wide CRISPR screen, we identified , , and as synthetic lethal partners with gilteritinib treatment in fms-like tyrosine kinase 3 ()-internal tandem duplication (ITD) acute myeloid leukemia (AML)...
3.
Stephens D, Huang Y, Ruppert A, Walker J, Canfield D, Cempre C, et al.
Clin Cancer Res
. 2022 May;
28(15):3242-3247.
PMID: 35608822
Purpose: Dual blockade of Bruton's tyrosine kinase with ibrutinib and selinexor has potential to deepen responses for patients with chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). Patients And Methods:...
4.
Walker J, Hing Z, Sher S, Cronin J, Williams K, Harrington B, et al.
Nat Commun
. 2021 Nov;
12(1):6338.
PMID: 34732719
Rare, recurrent balanced translocations occur in a variety of cancers but are often not functionally interrogated. Balanced translocations with the immunoglobulin heavy chain locus (IGH; 14q32) in chronic lymphocytic leukemia...
5.
Walker J, Hing Z, Harrington B, Baumhardt J, Ozer H, Lehman A, et al.
J Hematol Oncol
. 2021 Jan;
14(1):17.
PMID: 33451349
Background: Exportin 1 (XPO1/CRM1) is a key mediator of nuclear export with relevance to multiple cancers, including chronic lymphocytic leukemia (CLL). Whole exome sequencing has identified hot-spot somatic XPO1 point...